Literature DB >> 35818279

Lipid-apolipoprotein interactions in amyloid fibril formation and relevance to atherosclerosis.

Geoffrey J Howlett1, Timothy M Ryan2, Michael D W Griffin3.   

Abstract

The apolipoprotein family is a set of highly conserved proteins characterized by the presence of amphipathic α-helical sequences that mediate lipid binding. Paradoxically, this family of proteins is also prominent among the proteins known to form amyloid fibrils, characterized by extensive cross-β structure. Several apolipoproteins including apolipoprotein (apo) A-I, apoA-II and apoC-II accumulate in amyloid deposits of atherosclerotic lesions. This review illustrates the role of lipid-apolipoprotein interactions in apolipoprotein folding and aggregation with a specific focus on human apoC-II, a well-studied member of the family. In the presence of high concentrations of micellar lipid mimetics apoC-II adopts a stable and predominantly α-helical structure, similar to other members of the family and presumed to be the structure of apoC-II in circulating plasma lipoproteins. In contrast, lipid-free apoC-II aggregates to form long amyloid fibrils with a twisted ribbon-like morphology. Detailed structural analyses identify a letter G-like conformation as the basic building block within these fibrils. Phospholipids at submicellar concentrations accelerate apoC-II fibril formation by promoting the formation of a discrete tetrameric intermediate. Conversely, several small molecule lipid-mimetics inhibit apoC-II fibril formation at submicellar concentrations, inducing well-defined dimers unable to further aggregate. Finally, low concentrations of phospholipid micelles and bilayers induce the slow formation of amyloid fibrils with distinct rod-like fibril morphology. These studies highlight the diversity of lipid effects on apolipoprotein amyloid formation and reveal a conformational adaptability that could underlie the widespread occurrence of apolipoproteins in amyloid deposits and atheroma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apolipoprotein C-II; Cardiovascular disease; Metamorphic proteins; Polymorphism; Protein misfolding

Year:  2018        PMID: 35818279     DOI: 10.1016/j.bbapap.2018.08.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   4.125


  1 in total

1.  Use of appearance- and performance-enhancing drugs and substances is associated with eating disorder symptomatology among U.S. college students.

Authors:  Kyle T Ganson; Mitchell L Cunningham; Stuart B Murray; Jason M Nagata
Journal:  Eat Weight Disord       Date:  2022-01-22       Impact factor: 3.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.